EZH2 and hepatocellular carcinoma: At the same time, activation of SIRT7 super enhancer was found in all samples in hepatocellular carcinoma, and it was found that SIRT7 and methyltransferase EZH2 were co expressed and bound in hepatocellular carcinoma.